Michel M Afargan

Title: Discovering the Innovations of Inventor Michel M. Afargan

Introduction

Michel M. Afargan, an accomplished inventor based in Raanana, Israel, has made significant contributions to the field of pharmaceutical sciences. With a strong focus on somatostatin analogs, he holds two patents that showcase his innovative approach to drug development.

Latest Patents

Michel's latest patents revolve around "Conformationally constrained backbone cyclized somatostatin analogs." These patents detail novel peptides that exhibit somatostatin receptor subtype selectivity, highlighting their potential for improved therapeutic applications. The disclosed methods include synthesizing these somatostatin analogs and screening for their effectiveness. Additionally, the patents encompass pharmaceutical compositions that include these advanced somatostatin analogs, providing comprehensive insights into their practical applications in medicine.

Career Highlights

Throughout his career, Michel has worked with reputable companies such as Develogen Israel Ltd. and Peptor Limited. His experience in these firms has contributed to his expertise in pharmaceutical innovations, emphasizing his role in the development of critical health solutions.

Collaborations

Michel has collaborated with notable colleagues, including Vered Hornik and Gary Gellerman. These partnerships have facilitated the exchange of ideas and advances in research, significantly enhancing the development of his patented technologies.

Conclusion

Inventor Michel M. Afargan exemplifies the dedication and vision required to push the boundaries of pharmaceutical innovation. His extensive work with somatostatin analogs not only reflects his commitment to advancing science but also highlights the critical role of inventors in improving healthcare outcomes. Through his patents, Michel continues to pave the way for future breakthroughs in medicine.